SOLTF (Nxera Pharma Co) FFO


SOLTF Nxera Pharma Co Ltd SOLTF
84 GF Score
Price $6.37
GF Value $7.77
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Nxera Pharma Co FFO?

FFO (Funds from operations) only applies to REITs.

SOLTF
84GF Score
Nxera Pharma Co Ltd SOLTF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nxera Pharma Co (SOLTF) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of $6.37 is trading 18% below its estimated GF Value™ of $7.77. GuruFocus considers Nxera Pharma Co to be Modestly Undervalued.

Key valuation signals for SOLTF:

  • FFO:
  • GF Value™: $7.77 vs. price of $6.37 (18% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the SOLTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nxera Pharma Co Business Description

Other Exchanges 4565:Japan
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
84GF Score

Get the complete analysis for SOLTF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37
Price
$7.77
GF Value